Heart failure trials in Canada
80 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Cambridge, Chicoutimi, Greenfield Park, Hamilton, London, Montreal, Newmarket, New Westminster, North Vancouver, North York, Oakville, Oshawa, Ottawa, Peterborough, Saint-Jean-sur-Richelieu, Sydney, Thunder Bay, Toronto, Trois-Rivières, Vancouver, Waterloo, Winnipeg
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleAlleviant ALLAY-HFrEF Study
- Where
- Montreal, Newmarket, Québec
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT06812533 - No phaseTaking peopleSurgical Ablation of AF Efficacy Trial
- Where
- Hamilton
- Age
- 18 years and over
- People
- 2,000
- Run by
- Population Health Research Institute
See details and how to joinNCT05434819 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Brampton, Hamilton, Mississauga, Ottawa, Québec, Toronto, Vancouver, Winchester
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - Phase 3Taking peopleCOLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
- Where
- Hamilton
- Age
- 45 years and over
- People
- 2,500 worldwide
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT05873881 · EU 2023-506675-96-00 - Phase 1Taking peopleA Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
- Where
- Montreal
- Age
- 18 years to 100 years
- People
- 12 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07465653 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Barrie, Etobicoke, Greater Sudbury, Hamilton, Kingston, London, Markham, Montreal, Newmarket, North York, Oakville, Ottawa, Stoney Creek, Thunder Bay, Toronto, Trois-Rivières
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Calgary, Cambridge, Edmonton, Greater Sudbury, Kamloops, London, North Vancouver, North York, Regina, Sherbrooke, Surrey, Toronto, Vancouver, Winnipeg
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- Where
- Edmonton, Greater Sudbury, London, Montreal, North York, Sherbrooke, Surrey, Toronto
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06024746 - Phase 2/3Taking peopleMidodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
- Where
- Ottawa
- Age
- 18 years and over
- People
- 56
- Run by
- Ottawa Heart Institute Research Corporation
See details and how to joinNCT06405555 - Phase 2Taking peopleCOgnitioN With VERiciGuat Evaluation in Heart Failure
- Where
- Calgary, Edmonton, Montreal, Ottawa
- Age
- 18 years and over
- People
- 120
- Run by
- University of Alberta
See details and how to joinNCT06601465 - No phaseTaking peoplePharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Where
- Montreal, Toronto
- Age
- 0 years to 20 years
- People
- 5,000 worldwide
- Run by
- Duke University
See details and how to joinNCT04278404 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Burlington, Calgary, Chicoutimi, Courtice, Halifax, Hamilton, Kingston, Moncton, Montreal, North York, Oakville, Peterborough, Québec, Rimouski, Saint-Charles-Borromée, Scarborough Village, Sherbrooke, Toronto, Trois-Rivières, Vancouver, Waterloo, Winchester, Winnipeg
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleAlleviant ALLAY-HF Study
- Where
- Montreal, Newmarket
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT05685303 - No phaseTaking peopleVIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
- Where
- Hamilton, Thunder Bay, Toronto
- Age
- 18 years and over
- People
- 891 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT05724433 - Phase 2Taking peopleLumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients
- Where
- Toronto
- Age
- 18 years and over
- People
- 60
- Run by
- Qanatpharma AG
See details and how to joinNCT07695090 - Phase 3Taking peopleA Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- Where
- Calgary, Edmonton, Greater Sudbury, Kingston, London, North Vancouver, North York, Sherbrooke, Surrey, Toronto, Victoria, Winnipeg
- Age
- 18 years and over
- People
- 2,600 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06033950 - Phase 4Taking peopleThe STOP-MED CTRCD Trial
- Where
- Edmonton, Hamilton, Ottawa, Toronto, Winnipeg
- Age
- 18 years and over
- People
- 335 worldwide
- Run by
- Dinesh Thavendiranathan
See details and how to joinNCT06183437 - No phaseTaking peopleTed Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
- Where
- Newmarket, Toronto
- Age
- 18 years and over
- People
- 360
- Run by
- University Health Network, Toronto
See details and how to joinNCT07447908 - No phaseTaking peopleRAFT - Pace &Ablate
- Where
- Halifax, Hamilton, Kitchener, London, Montreal, Newmarket, Ottawa, Québec, Sherbrooke, Toronto, Victoria
- Age
- 18 years and over
- People
- 600
- Run by
- Habib Khan
See details and how to joinNCT06299514 - No phaseTaking peopleMedlyPeds Feasibility Study
- Where
- Toronto
- Age
- 8 years to 18 years
- People
- 30
- Run by
- The Hospital for Sick Children
See details and how to joinNCT07556185 - Phase 2Taking peopleInhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation
- Where
- Montreal
- Age
- 18 years and over
- People
- 141
- Run by
- Montreal Heart Institute
See details and how to joinNCT05450328 - No phaseTaking peopleJUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
- Where
- Toronto
- Age
- 18 years to 79 years
- People
- 300
- Run by
- Women's College Hospital
See details and how to joinNCT06930521 - No phaseTaking people3D Assessment of RV Function in Patients Undergoing LVAD Implantation
- Where
- Edmonton
- Age
- 16 years and over
- People
- 200
- Run by
- University of Alberta
See details and how to joinNCT05376254 - No phaseTaking peopleEffects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Where
- Calgary, Hamilton, Montreal, Ottawa, Québec, Toronto
- People
- 420 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT01790152